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Abstract
The mechanisms that control proliferation and differentiation of embryonic lung mesenchyme are largely unknown. We describe an
explant system in which exogenous recombinant N-Sonic Hedgehog (N-Shh) protein sustains the survival and proliferation of lung
mesenchyme in a dose-dependent manner. In addition, Shh upregulates several mesenchymal cell markers, including its target gene Patched
(Ptc), intercellular signaling genes Bone Morphogenetic Protein-4 (Bmp4) and Noggin (Nog), and smooth muscle actin and myosin. In
explants exposed to N-Shh in the medium, these products are upregulated throughout the mesenchyme, but not in the periphery. This
exclusion zone correlates with the presence of an overlying mesothelial layer, which, as in vivo, expresses Fibroblast Growth Factor 9
(Fgf9). Recombinant Fgf9 protein inhibits the differentiation response of the mesenchyme to N-Shh, but does not affect proliferation. We
propose a model for how factors made by two epithelial cell populations, the inner endoderm and the outer jacket of mesothelium,
coordinately regulate the proliferation and differentiation of the lung mesoderm.
© 2003 Elsevier Science (USA). All rights reserved.
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Introduction
Reciprocal epithelial–mesenchymal interactions are es-
sential for the growth, differentiation, and patterning of
many vertebrate organs. One of these is the embryonic
mouse lung, which has proved a valuable model system for
studying the molecular basis of signaling between embry-
onic tissue layers. The lung arises from the ventral foregut
at embryonic day 10 (E10) as two primary buds, each
consisting of three cell layers: the inner epithelium (of
endodermal origin), the surrounding mesenchymal stroma,
and a thin outer mesothelium. Early in development, the
epithelium undergoes a stereotypic pattern of branching
morphogenesis that is dependent on signals from the mes-
enchyme. Considerable work has focused on the molecular
mechanisms controlling this branching and the proximal–
distal differentiation of the respiratory epithelium (reviewed
in Cardoso, 2001; Hogan et al., 1997). By contrast, rela-
tively little is known about tissue interactions regulating the
development of the mesenchyme.
The cellular composition of the mesenchyme is complex
and involves the distinct patterning of different cell types.
One of the most obvious patterns is seen in smooth muscle,
the development of which is temporally and spatially coor-
dinated with that of the respiratory epithelium. At the level
of the main bronchi, smooth muscle overlies the dorsal
surface of the endoderm, while cartilaginous rings partially
encompass the ventral airways. In all successive proximal
airways, smooth muscle cells encircle the entire endoderm,
but are characteristically absent from the advancing tips of
distal airways during branching morphogenesis (Tollet et
al., 2001). In addition to smooth muscle and cartilage, there
is evidence that early distal mesenchyme gives rise to en-
dothelial cells of blood vessels and pericytes by the process
of vasculogenesis (deMello et al., 1997; Partanen et al.,
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Fig. 1. Bmp4lacZ and NoglacZ are expressed in overlapping domains in the lung mesenchyme. (A) Ventral view of Bmp4lacZ expression in E11.5 lung. (B)
Section through E11.5 Bmp4lacZ lung. Note strong expression in mesenchyme cells adjacent to main bronchi (arrow), proximal endoderm, and in interbud
regions. Boxed area shown at higher magnifications in (C) and (D). (E) Ventral view of NoglacZ expression in E11.5 lung. (F) Section through the same. Boxed
area shown at higher magnification in (G). (G) NoglacZ-expressing cells are directly adjacent to the proximal epithelium and in interbud regions. (H) Low,
“salt-and-pepper” staining of NoglacZ-positive cells in distal mesenchyme at E11.0. (I) Ventral view of Bmp4lacZ lung at E13.5. (J) High magnification of main
bronchi in (I). (K) Section through E13.5 Bmp4lacZ lung. Note gradient of Bmp4lacZ activity, with highest expression adjacent to epithelium decreasing toward
periphery. (L) Ventral view of NoglacZ expression at E13.5 but slightly more advanced than in (I). (M) Main bronchi of lung shown in (L). Expression is
seen in developing cartilage rudiments (arrow) and parabronchial smooth muscle. (N) Section through E13.5 NoglacZ lung. Expression restricted to cells
directly adjacent to proximal epithelium. All sections counterstained with eosin. Asterisks in (C) and (K) indicate Bmp4lacZ expression in distal epithelium.
Scale bar in (A), 300 m in (A, E, J, M); 800 m in (I, L). Scale bar in (C), 200 m in (C, G); 400 m in (B, F, K, N); 100 m in (D, H).
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1996) and to artery-associated smooth muscle (Hall et al.,
2000). Postnally, the distal mesoderm generates myofibro-
blasts in the tips of the alveolar septae (Bostrom et al., 1996;
Kapanchi, 1997). Additional cell types found in the lung
include stromal fibroblasts, interstitial lipofibroblasts
(McGowan and Torday, 1997), and lymphatic vessels.
Insight into lung mesenchyme development comes from
both cellular and genetic studies. Lung mesenchyme cul-
tured in vitro in the absence of endoderm fails to undergo
either morphogenesis or differentiation, even in the pres-
ence of 10% serum (Gebb and Shannon, 2000; Taderera,
1967). This suggests that the endoderm normally releases
components required by lung mesenchyme, and several
lines of genetic evidence point to Sonic hedgehog (N-Shh)
as one factor involved. First, Shh is expressed in lung
endoderm from the earliest stages of development, and
protein is detected in respiratory epithelial cells from E10.5
until birth (Bellusci et al., 1997; Bitgood and McMahon,
1995; Miller et al., 2001). The gene encoding its receptor
and downstream target, Ptc, is also transcribed in a dynamic
pattern in the lung mesenchyme (Bellusci et al., 1997;
Motoyama et al., 1998; this paper). Second, Shh homozy-
gous null mutant mice have severely hypoplastic lungs;
proliferation of the mesenchyme is reduced, and parabron-
chial smooth muscle differentiation is absent (Litingtung et
al., 1998; Pepicelli et al., 1998). Third, transgenic overex-
pression of Shh in the endoderm leads to increased amounts
of highly proliferative mesoderm (Bellusci et al., 1997).
Finally, all three Gli genes (Gli1, Gli2, and Gli3) encoding
downstream intracellular regulators of Shh signaling are
expressed in overlapping domains in the mesoderm (Grind-
ley et al., 1997; Hui et al., 1994; Platt et al., 1997). Embryos
lacking combinations of Gli genes exhibit a spectrum of
lung defects, ranging from abnormally shaped and fused
lobes to complete absence of lung buds in Gli2/; Gli3/
compound mutants (Grindley et al., 1997; Motoyama et al.,
1998; Park et al., 2000). Taken together, these phenotypes
suggest that the Shh signaling pathway has multiple roles in
mesenchymal cell proliferation, differentiation, and pattern-
ing.
There is evidence that another cell layer, the outer me-
sothelium, is also essential for lung mesenchymal develop-
ment. Mutation of Fibroblast growth factor 9 (Fgf9), ex-
pressed at high levels in the mesothelium, results in a
decrease in stromal proliferation. Although the lung epithe-
lium differentiates normally and the pulmonary vasculature
is present, this loss of mesenchymal mass results in a
smaller lung, with fewer generations of epithelial branches
(Colvin et al., 1999, 2001). However, the precise mecha-
nisms by which Fgf9 affects lung mesenchyme develop-
ment remain largely unexplored.
Here, we have developed an explant system to examine
the mechanisms controlling lung mesoderm survival, differ-
entiation, and patterning. We show that N-Shh promotes
mesenchymal cell proliferation, the expression of genes
encoding several intercellular signaling factors, and the dif-
Fig. 2. Parabronchial smooth muscle cells coexpress NoglacZ, Bmp4lacZ,
and sma. (A) Nomarski bright-field of Bmp4lacZ activity (blue) in a wide
domain of the lung mesenchyme (black bracket). (B) Sma is detected in a
subset of Bmp4lacZ-positive cells adjacent to the endoderm (white bracket).
(C) NoglacZ expression. (D) Sma-expressing cells are confined to the
NoglacZ-expressing cell layer. (E) High magnification of distal tip in (C).
Note two populations of NoglacZ-expressing cells: smooth muscle adjacent
to the proximal endoderm, and cells with a “salt-and-pepper” distribution
more distally (arrow). (F) The first population coexpresses sma; the second
does not. (G) Nomarksi image of NoglacZ proximal airway and adjacent
blood vessel (*). (H) Only parabronchial smooth muscle is positive for
NoglacZ. Both blood vessel-associated smooth muscle and parabronchial
smooth muscle stain with sma. (I, J) Pecam antibody staining (purple)
counterstained with eosin. NoglacZ cells (blue) do not colocalize with large
vessels in proximal regions (I) or with capillaries in distal regions (J).
Boxed region in (I) is shown at higher magnification in (J). All lungs are
E13.5. Scale bar in (A), 400 m in (A–D); 200 m in (I); 800 m in
(E–H).
171M. Weaver et al. / Developmental Biology 258 (2003) 169–184
ferentiation of smooth muscle. By contrast, we demonstrate
that Fgf9 produced by the mesothelium inhibits the upregu-
lation of signaling factors and the differentiation of smooth
muscle in response to Shh. Taken together, the results sug-
gest a model for how the endoderm and the mesothelium
cooperate in vivo to regulate the development of the inter-
vening mesoderm.
Materials and methods
Embryos and mouse strains
Wildtype embryos were from ICR outbred mice (Harlan-
Sprague-Dawley, Indianapolis, IN). Mice carrying the lacZ
reporter alleles Bmp4lacZ, NoglacZ, and Flk1lacZ have been
described (Lawson et al., 1999; McMahon et al., 1998;
Shalaby et al., 1995). NoglacZ homozygotes were obtained
by intercrossing.
Mesenchyme and endoderm isolation
E11.5 embryos (noon on the day of vaginal plug is E0.5)
heterozygous for the lacZ reporter allele were genotyped by
staining hindlimbs for -galactosidase activity. Lungs were
washed two times in Tyrode–Ringer’s solution and incu-
bated in pancreatin–trypsin solution (Hogan et al., 1994) for
7–9 min on ice. Mesenchyme and endoderm were then
separated by using tungsten needles in DMEM with 5%
fetal bovine serum. Tightly adherent mesothelium was not
specifically removed during dissection although its disrup-
tion was inevitable.
Tissue recombinations and mesenchyme explants
Each explant consisted of the total mesenchyme distal to
the primary bronchi from one E11.5 lung, cultured on an
8-m Nucleopore track-etch filter (Whatman #110414,
Clifton, NJ) floating on Schuger’s mesenchyme culture me-
dium (Yang et al., 1998). This is Minimal Essential Medium
(MEM) (Mediatech, VA) containing nonessential amino
acids, 100 U/ml penicillin, 100 g/ml streptomycin, 0.29
mg/ml L-glutamine, and 10% fetal bovine serum (Summit
Biotechnology, Fort Collins, CO). In some cases, a single
whole lobe (mesenchyme  endoderm) was cultured as a
control. Cultures were incubated in 95% air/5% CO2 at
37°C for a total of 72 h and fixed for 5 min in 4% parafor-
maldehyde in PBS at 4°C before X-gal staining and further
processing.
For recombinations, mesenchyme from single heterozy-
gous NoglacZ/ lungs was collected and cultured as above.
After 24 h, freshly isolated E11.5 wildtype endoderm was
placed adjacent to the mesenchyme and cultured for an
additional 48 h.
Varying concentrations of recombinant, octyl modified
N-Shh (a generous gift of Curis, Inc., Cambridge, MA) were
added at the start of culture, either to the medium or loaded
on beads. Fgf-loaded beads were added 24 h after the start
of culture.
To determine cell numbers, explants were incubated on
ice for 15 min in Tyrode–Ringer’s solution (Hogan et al.,
1994), then for 15 min in 0.25% trypsin–EDTA (Gibco-
BRL) at 37°C. After adding an equal volume of Shuger’s
medium, a single cell suspension was obtained by gentle
agitation and cells counted using a hemocytometer. Mean
differences between the log numbers of cells/ml in treat-
ments were examined by an analysis of variance procedure,
and additionally, an adjustment for multiple comparisons
was applied. The results were still statistically significant
after adjustment using the Tukey multiple comparisons pro-
cedure. This analysis was performed by using the SAS (SAS
Inc., Cary, NC) system, version 8.1.
For cell proliferation assays, 5-bromo-2-deoxyuridine
and 5-fluoro-2-deoxyuridine (Amersham, Buckingshire,
England) was added at a 1:1000 dilution after 64 h. Explants
were rinsed and fixed after 72 h of culture, and labeled cells
were detected with the Cell Proliferation Kit (Amersham),
except using fluorescent conjugated secondary antibodies
(see below).
Preparation of protein loaded beads
For delivery of Fgf, acrylic beads with immobilized
heparin (Sigma H-5263) were rinsed with PBS three times.
Beads of approximately 125–175 m in diameter were
placed in siliconized tubes (25 beads/tube) and rotated in 25
ng/l recombinant human Fgf9 (R&D Systems, Minneap-
olis, MN), 50 ng/l recombinant human Fgf10 (generous
gift of Dr. Nobuyuki Itoh, or purchased from R&D Sys-
tems), or 0.1% BSA for 30 min at 37°C, as described
(Kettunen and Thesleff, 1998), and subsequently washed
extensively in MEM. Activity of Fgf10 was confirmed by
using an endoderm migration assay (Weaver et al., 2000).
For delivery of Shh, Affi-gel Blue Gel beads (100–200
mesh) (Bio-Rad #153-7302, Hercules, CA) were washed
and sorted as above and incubated in recombinant, octyl
N-Shh (3 or 1 g/l) (gift of Curis, Inc.), or 0.1% BSA for
1 h at 37°C.
LacZ activity
Tissues fixed in 4% paraformaldehyde were incubated in
X-gal substrate solution (Hogan et al., 1994) for 14 h at
37°C. After washing and postfixation, samples were dehy-
drated in an isopropanol series, embedded in paraffin, and
sectioned at 7 m. Histoclear (National Diagnostics, At-
lanta, GA) was used for embedding and dewaxing.
Immunohistochemistry
Immunohistochemistry was performed on paraffin-em-
bedded sections of intact lungs or explants fixed in 4%
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paraformaldehyde. Some of these samples were previously
stained for lacZ activity as above. Immunohistochemical
reactions were carried out in parallel with control reactions
lacking primary antibodies.
Immunofluorescence
Primary antibodies used include: mouse monoclonal
anti- smooth muscle actin (sma) (clone 1A4) (Sigma, St.
Louis, MO), at 1:200 or 1:400 dilution and incubated at
room temperature for 1 h; rabbit polyclonal anti-smooth
muscle myosin (Biomedical Technologies, Inc., Stoughton,
MA) at 1:100 dilution after antigen retrieval with 20 g/ml
proteinase K at room temperature for 5 min; rabbit poly-
clonal anti-phospho-Histone H3 (Upstate Biotechnology,
Lake Placid, NY) at 1:1000 dilution incubated at room
temperature overnight after microwave antigen retrieval
with 10 mM sodium citrate; polyclonal rabbit anti-human
pan cytokeratin (Dako, Carpinteria, CA) at 1:500 dilution
after proteinase K treatment as above. With the exception of
sma, primary antibodies were incubated at 4°C overnight.
Cy2 and Cy3 fluorescent conjugated antibodies from Jack-
son ImmunoResearch (West Grove, PA) were used accord-
ing to the manufacturer’s instructions. Secondary incuba-
tions were at room temperature for 1 h. Tissue was
counterstained in 0.1 g/ml DAPI at room temperature for
5 min.
Immunochromagen
Immunostaining for Pecam/CD31 on paraformaldehyde-
fixed, paraffin-embedded sections was performed essen-
tially as described (Kalinichenko et al., 2001a). Briefly,
slides were treated with 1% trypsin in PBS for 5 min at
37°C to retrieve antigen, then incubated with rat monoclo-
nal anti-pecam antibody (clone MEC13.3) (BD PharMin-
gen, #550274) at a 1:50 dilution overnight at 4°C. Second-
ary antibody was biotinylated donkey anti-rat (Jackson
ImmunoResearch) at 1:200 dilution for 1 h at room temper-
ature. Signal was amplified by using streptavidin–horserad-
ish peroxidase conjugate (Vectastain Elite ABC Kit; Vector,
Burlingame, CA) and visualized with 3,3-diaminobenzi-
dine substrate (Vector). Tissues were counterstained with
eosin.
Radioactive in situ hybridization
35S-labeled anti-sense and sense riboprobes were pre-
pared by using the Boehringer Mannheim RNA labeling kit
and 850-bp Fgf9 (Colvin et al., 1999) and 841-bp Ptc (Platt
et al., 1997) cDNA templates. All probes were hybridized in
50% formamide hybridization mix (Hogan et al., 1994),
except those for Fgf9, which were hybridized in 55% for-
mamide to decrease background. Slides were exposed to
emulsion for 2 (Ptc) or 4 (Fgf9) days and counterstained
with hematoxylin. Twenty-four-hour fixation of explants
was required for detection of Fgf9 in the mesothelium.
Scanning electron microscopy
Explants cultured for 72 h were fixed in 2% glutaralde-
hyde in phosphate buffer. Controls were accessory lobes
from lungs exposed to the same conditions as explants,
including pancreatin–trypsin treatment. Samples were
rinsed for 5 min in PBS, pH 7.4, after which they were
postfixed in 1% buffered osmium tetroxide for 30 min,
rinsed with distilled water, and dehydrated in a graded series
of ethanol. The samples were dried in a Balzer 020 critical
point drying unit by using bone dry CO2. After mounting on
aluminum stubs and gold coating in a Pelco SC-6 sputter
coater, samples were viewed in a Hitachi s-2700 scanning
electron microscope. Images were acquired digitally by
using the Hitachi Quartz PCI imaging system.
Results
Temporal and spatial patterns of expression of NoglacZ,
Bmp4lacZ, and Ptc in lung mesenchyme
As a prerequisite to the analysis of lung mesenchyme devel-
opment, we first established the precise spatial patterns of expres-
sion of several important signaling genes transcribed in this tissue,
including Bmp4lacZ, NoglacZ, and Ptc (Bellusci et al., 1996; Brunet
et al., 1998; Lawson et al., 1999; McMahon et al., 1998; Weaver
et al., 1999). As shown in Figs. 1 and 2, Bmp4lacZ and NoglacZ are
active in overlapping but not identical domains of lung mesoderm.
At E11.5, Bmp4lacZ activity is seen in a wide swath of cells, with
highest levels adjacent to the proximal epithelium and lower levels
toward the periphery (Fig. 1A–D). At the same stage, strong
NoglacZ expression is restricted to one or two cell layers immedi-
ately adjacent to the proximal epithelium (Fig. 1E–G). In addition,
NoglacZ-positive cells are scattered throughout most of the distal
mesoderm; these cells appear to express low levels of Nog, since
their visualization requires long periods of staining and the Xgal
product is punctate (Fig. 1H; see also Fig. 2C, E, and J). These
overall expression patterns are maintained at E13.5 (Fig. 1I–N),
and Nog-positive cells are also visible at this time in the develop-
ing cartilage rings around the trachea and primary bronchi (Fig.
1M).
The location of NoglacZ-positive cells adjacent to the
proximal endoderm suggested that they are parabronchial
smooth muscle (Tollet et al., 2001). This hypothesis was
confirmed by colocalization in tissue sections of high levels
of -galactosidase activity and sma in these cells, at all
stages examined (E11.5, E13.5, E14.5, E15.5) (Fig. 2C–H,
and data not shown). By contrast, NoglacZ is neither ex-
pressed in perivascular smooth muscle (pericytes) associ-
ated with blood vessels and capillary beds, nor in the Pe-
cam-expressing endothelial cells themselves (Fig. 2G–J).
The domain of Bmp4lacZ expression includes sma-posi-
tive cells adjacent to the endoderm, but also extends beyond
it (Fig. 2A and B). Differentiated parabronchial smooth
muscle therefore coexpresses Bmp4lacZ and NoglacZ, at least
during the pseudoglandular stage of lung development.
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Fig. 3. Nog mutant lung phenotype. Ventral view of wild-type (A) and Nog/ (E) lungs at E15.5. All Nog/ lungs examined have abnormal gross
morphology, with malformed and truncated lobes (E). Dorsal view of E15.5 wild-type (B) and mutant (F) lungs injected with India ink. An ectopic bud is
evident between the two main bronchi in the mutant (arrow). Smooth muscle myosin immunostaining (green) and DAPI nuclear staining (blue) of wild-type
(C) and mutant (G) lungs at E13.5. A central diverticulum (d) surrounded by smooth muscle is observed between the main bronchi (b) in the mutant. Sma
immunostaining (red) and Nomarksi bright-field of wild-type (D) and mutant (H) E15.5 lungs. Smooth muscle differentiation appears normal in the mutant
lung. Bar in (A) 1 mm in (A, E); 600 m in (B, F); Bar in (C), 200 m in (C, D, G, H).
Fig. 4. Patched expression in lung. In situ hybridization in E11.5 lung. (A, B) Ptc is expressed in distal mesenchyme surrounding endodermal buds. At E12.5
(C, D), Ptc transcripts are high in distal mesenchyme and lower around more proximal airways (single arrowhead) and main bronchi (three arrowheads). At
E13.5 (E, F), Ptc transcripts are high distally and at lower levels along the main bronchi (arrowheads). Scale bar in (A), 250 m for (A–F).
Given the high expression of NoglacZ in parabronchial
smooth muscle, we examined the phenotype of these cells in
Nog homozygous null embryos. All the lungs of these embryos
examined (n 30) exhibited abnormal gross morphology with
malformed and truncated lobes (Fig. 3A and B, E and F).
Seventy-eight percent (22/28) had fusions of the right lobes,
with varying degrees of severity (data not shown), while 31%
(9/29) had a blind-ended ectopic bud or diverticulum emerging
near the junction of the main bronchi (Fig. 3F and G). How-
ever, smooth muscle actin and myosin immunostaining (Fig.
3C and D, G and H) and transmission electron microscopy
(data not shown) did not detect abnormalities in the smooth
muscle cells associated with proximal airways.
It has been reported by several groups that Ptc, which
encodes both a receptor for Shh and a transcriptional target of
Shh signaling, is transcribed at high levels in the distal lung
mesenchyme (Bellusci et al., 1997; Litingtung et al., 1998;
Motoyama et al., 1998; Pepicelli et al., 1998). These studies
had reported expression at E11.5 but had not examined later
stages. Our data (Fig. 4) confirm the high levels of Ptc tran-
script in distal mesenchyme at E11.5 and show that they are
maintained at E12.5 and E13.5 (Fig. 4A–F). In addition, how-
ever, lower levels of Ptc transcript are evident surrounding
more proximal airways at both later stages. For example, at
E12.5, strong Ptc signal is detected around proximal airways
and the main bronchi (Fig. 4D, white arrows), while low levels
can also be detected along the main bronchus at E13.5 (Fig. 4F,
white arrows). Thus, cells throughout the lung mesenchyme,
including putative smooth muscle cells around more proximal
airways, may be responding to Shh signal in vivo.
Endoderm is required for mesenchymal cell proliferation
and Noggin and Bmp4 expression in vitro
Previous studies determined that endoderm of E11.5
lungs produces factors required for the morphogenesis and
differentiation of the mesenchyme (Gebb and Shannon,
2000; Taderera, 1967). We confirmed this by culturing
isolated distal endoderm and mesoderm in the presence of
10% serum (Fig. 5). Under these conditions, mesenchyme
alone spreads as a thin layer over the filter (Fig. 5A–C), and
the cells express neither NoglacZ (n 10) (Figs. 5D and 6A)
nor Bmp4lacZ (n  14) (Fig. 6E) after 72 h of culture. Since
mesenchyme initially expresses both of these reporters (Fig.
1), this loss of expression is due to either death of the
expressing cells or shutoff of gene transcription. If wildtype
(/) endoderm is added after 24 h, the endoderm and
mesenchyme reassociate and the endoderm branches within
the mesenchyme (Fig. 5F and G). Moreover, the mesenchy-
mal cells immediately adjacent to the endoderm express
NoglacZ, presumably in smooth muscle cells (Fig. 5H; n 
3/4 lacZ-positive at 48 h; n  12/12 lacZ-positive at 72 h).
The lacZ activity in these cells verifies that they are derived
from the cultured mesenchyme and not from any wildtype
mesenchyme carried over with the endoderm. As a control,
whole accessory lobes from NoglacZ/ lungs consistently
express localized NoglacZ at both 48 h (n  5/5) and 72 h (n
 13/13) (data not shown). These results confirm that lung
endoderm can maintain the survival of the mesenchyme and
further suggest that factor(s) from the endoderm either in-
duce NoglacZ expression, or promote the survival of NoglacZ-
expressing cells, or both.
Proliferation in response to Shh
We next asked whether recombinant N-Shh protein can
substitute for endoderm in the explant system. Explants
exposed to increasing doses of Shh are shown in Fig. 6A–D.
If Shh is added to the culture medium at 300 ng/ml (n 12),
1 g/ml (n  3), and 3 g/ml (n  44), the number of cells
increases in a dose-dependent manner compared with con-
trols. Before culture, mesenchyme explants contain, on av-
Fig. 5. Endoderm promotes survival and gene expression in lung mesenchyme. Isolated NoglacZ/ mesenchyme becomes granular and disintegrates over
72 h of culture (A–C), and NoglacZ-expressing cells are not maintained (D). When isolated wildtype endoderm (arrows) is added to the cultures after 24 h
(F), endodermal and mesenchymal components rapidly reassociate and endoderm (arrows) branches within the mesenchyme (G). NoglacZ-positive mesen-
chymal cells are present adjacent to endoderm (H). Note that these cells are detected in proximal regions of the endoderm (arrow) but not surrounding the
extending distal tip (asterisk), as observed in vivo (Fig. 2). Scale bar is 400 m in (A–C, E–G); 300 m in (D); and 200 m in (H).
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erage, 3.7  105 cells/ml (9.8  104, n  6). By 72 h in
the absence of Shh, the cell number declines eightfold, to
4.6  104/ml (2.2  104, n  6). In contrast, with
addition of 300 ng/ml Shh, the average number of cells
increases threefold to 1.2  106/ml (1.8  105, n  6).
With 3 g/ml Shh treatment, an almost ninefold increase is
seen, with 3.3  106 cells/ml (3.8  105, n  6). These
numbers are significantly different (P  0.0001; see Mate-
rials and methods). Labeling of cultures with BrdU or Phos-
pho-histone H3, a marker of cells in mitosis, shows that
proliferating cells are present throughout the explants, in-
cluding the outer layer and periphery (Fig. 6I; see Fig. 9G
and H). Based on these findings, subsequent experiments
were carried out with 3 g/ml Shh in the medium.
Gene expression and cell differentiation in response to
Shh
To further assess the response of lung mesenchyme to
Shh, we examined gene expression and cellular differenti-
ation. Cultures exposed to 3 g/ml Shh show high but
nonuniform expression of Ptc (n  4), NoglacZ (n  24),
and Bmp4lacZ (n  7) throughout the explant (Fig. 6F–H).
The increase in NoglacZ expression was dose-dependent
with increasing concentrations of Shh treatment (Fig.
6B–D).
It has been reported that Shh indirectly promotes angio-
genesis of blood vessels in vivo (Pola et al., 2001). We
therefore examined the effect of N-Shh on the expression of
Flk1lacZ, a marker of endothelial cells. After 72 h, there are
FlklacZ-positive cells throughout explants treated with 3
g/ml Shh (n  4) (Fig. 6H). Again, the extent of the
staining is dose-dependent, with increasing numbers of
FlklacZ-positive cells observed with increasing concentra-
tions of Shh (data not shown).
Finally, we asked whether the expression of smooth
muscle markers is affected by exogenous Shh. As shown in
Fig. 7, in the presence of 3 g/ml Shh, there is strong
immunolocalization of both sma and smooth muscle myosin
(smm) throughout explants, in a nonuniform pattern. In
some regions, there is coincidence between the high NoglacZ
and high sma expression; but in other areas, cells that
express high levels of NoglacZ apparently stain only weakly
for sma, and vice versa (compare Fig. 7A and B). This is
also the case in vivo, where only a subset of smooth muscle-
positive cells also expresses NoglacZ (see Fig. 2).
Fig. 6. Dose-dependent growth and gene expression in Shh-treated explants. NoglacZ/ lung mesenchyme cultured for 72 h without N-Shh forms a thin
layer of cells (A). With 300 ng/ml (B), 1 g/ml (C), or 3 g/ml (D) of N-Shh, explants survive and proliferate, and increasing levels of NoglacZ activity are
observed. Explants cultured for 72 h without N-Shh exhibit no Bmp4lacZ activity (E). Explants cultured in 3 g/ml Shh show expression of Bmp4lacZ (F),
Ptc (G), and Flk1lacZ (H). Immunostaining of explants for phospho-histone H3 (red), counterstained with DAPI (blue) (I) illustrates proliferation throughout
the explant. Scale bars in (D, H), 400 m for (A–F, H); in (I), 200 m for (G, I).
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Lung mesenchyme explants are covered by mesothelium
In mesenchyme explants, we consistently observed zones
about five to eight cell diameters wide at the periphery that
have low or no expression of NoglacZ, Bmp4lacZ, sma, and
Flk1lacZ (Fig. 6F and H; between black bars in Fig. 7A, C,
and G and white bars in Fig. 7B and D). We hypothesized
that these nonexpressing regions are associated with the
mesothelium, a squamous epithelium that covers the outer
surface of the embryonic lung in vivo. We tested whether
this layer is maintained in vitro using a pan-cytokeratin
antibody that stains epithelial cells, including the lung me-
sothelium, but not mesenchyme. As shown in Fig. 7G and
H, wherever mesothelial-like cells are detected in sections
of NoglacZ explants, they are underlain by a domain of low
NoglacZ activity.
To confirm the presence and integrity of mesothelial
cells in the culture system, we compared the phenotype of
cells on the outer surface of explants with that of normal
lung mesothelium. First, histological analysis of sectioned
explants shows that the outer cells have a thin, squamous
morphology, similar to that of cells covering the E13.5 lung
(Fig. 8A and B), and very different from that of the endoder-
mal epithelium, which is cubical or columnar (asterisk, Fig.
8A). This similarity extends to the scanning electron micro-
scope level, where cells on the surface of both explants and
normal E11.5 accessory lobes exhibit the characteristic
shape and surface microvilli of mesothelial cells (Mutsaers,
2002) (Fig. 8C and D). Finally, cells on the outer surface of
explants, like the mesothelium of the normal embryonic
lung, express Fgf9 (Fig. 8E–H; and Colvin et al., 1999).
Fgf9 influences mesenchyme differentiation
Our results suggest that factors released by the mesothe-
lium of explants influence the differentiation of underlying
mesenchymal cells. One candidate for mediating this effect,
both in vivo and in vitro, is Fgf9. Two potential receptors
for this protein, FgfR1IIIc and FgfR2IIIc, are expressed in
lung mesenchyme (Cardoso et al., 1997; Colvin et al., 2001;
Orr-Urtreger et al., 1993; Peters et al., 1992). We tested this
hypothesis by implanting Fgf9-loaded beads into explants
that had been cultured in 3 g/ml N-Shh for 24 h. Under
these conditions, NoglacZ expression is inhibited around the
bead (n  8/8) (Fig. 9A and C). By contrast, this inhibitory
effect is not seen with beads loaded with either PBS (n 
0/10) or Fgf10, a factor which signals through an alternative
receptor to Fgf9 (n  0/7) (Fig. 9B and D). Fgf9-soaked
beads also inhibit the differentiation of sma-positive cells
(Fig. 9E, n  13), an effect not seen with Fgf10 (Fig. 9F; n
 7) or PBS beads (data not shown; n  3). BrdU incor-
poration studies did not detect any difference in cell prolif-
eration levels surrounding beads loaded with either Fgf9
(Fig. 9G; n  7) or Fgf10 (Fig. 9H; n  4). Rather,
proliferation appears uniform throughout the explant.
Locally applied Shh upregulates Ptc and Bmp4 in lung
mesenchyme explants
To test the local action of Shh, we applied N-Shh-loaded
beads to mesenchyme explants. In these cases, the expres-
sion of both Ptc (Fig. 10A and B) and Bmp4lacZ (n 13/15)
(Fig. 10E and G) is localized around the bead. However,
Fig. 7. Gene transcription and cell differentiation in explants cultured for
72 h with 3 g/ml Shh. (A) Robust NoglacZ activity throughout a section of
an explant culture. Note that expression is absent in some peripheral
regions (between black bars). (B) Sma immunostaining of the section in
(A). High smooth muscle actin levels are observed throughout the explant,
but these regions do not precisely coincide with NoglacZ expression. Note
that sma is absent from the same peripheral regions as Nog expression
(white bars, see also D). (C–F) Endothelial and smooth muscle cells are
both present in explant cultures. (C) Section of Flk1lacZ/ explant re-
veals the presence of endothelial cells. Strong sma immunostaining (D) is
observed in the explant, but is excluded from Flk1lacZ-positive cells. Note
that, in some peripheral regions, sma staining and Flk1lacZ activity are both
excluded (white and black bars, respectively). Tissue stained with DAPI
(E) and antibody to smooth muscle myosin (F) confirms the presence of
smooth muscle in explants. (G) A peripheral zone lacking NoglacZ expres-
sion (black bars) is covered with mesothelium, marked by immunostaining
for pan-cytokeratin (white bars) (H). Scale bar in (A), 200 m in (A–D);
100 m in (G, H).
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proliferation occurs throughout the explant (Fig. 10C and
D). Compared with Ptc and Bmp4lacZ, a much less uniform
distribution of NoglacZ (Fig. 10F and H; n  9/9) and sma
expression (Fig. 10I and J) is seen relative to the Shh-loaded
beads, and the two products do not always colocalize. The
reason for this result is not clear, but suggests that some
responses to a localized source of Shh are particularly sen-
sitive to factors such as local cell density and uneven ex-
tracellular matrix accumulation.
Discussion
The patterning and differentiation of the mesenchyme in
the developing lung is a largely unexplored area. Here, we
have established an explant assay system in which N-Shh
can substitute for some of the well-documented functions of
the lung endoderm in supporting the survival, proliferation,
and differentiation of the mesoderm (Gebb and Shannon,
2000; Taderera, 1967) (Fig. 5). Using this assay, we can, for
Fig. 8. Characterization of mesothelial cells. Mesothelial cells of the wildtype lung (A) (between black bars) are squamous, contrasting with cuboidal
endodermal cells (*). (B) Cells covering a Shh-treated explant (between black bars) exhibit similar squamous morphology. (C) Scanning electron micrograph
of an isolated E11.5 accessory lobe shows characteristic mesothelial cells with surface microvilli. (D) Cells with similar morphology on the surface of an
explant after 72 h. (E) Hematoxylin-stained E13.5 lung lobe. (F) Hematoxylin-stained explant. (G) Fgf9 transcript is detected in putative mesothelial cells
at the periphery of an E13.5 lung lobe. (H) Fgf9 transcript is detected at the periphery of the explant. All explants shown were treated with 3 g/ml Shh.
Scale bars in (A), 50 m in (A, B); in (C), 15 m in (C, D); in (E), 100 m in (E–H).
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Fig. 9. Fgf9 inhibits NoglacZ transcription and sma levels in Shh-treated explants. A distinct domain of cells lacking NoglacZ activity is observed around an
Fgf9-loaded bead implanted into Shh-treated lung mesenchyme (A). A control Fgf10-loaded bead does not affect NoglacZ expression (B). A section from
another explant confirms that both NoglacZ expression (C) and sma immunostaining (E) are decreased in a ring of cells surrounding an Fgf9 bead. A section
of an explant treated with an Fgf10-loaded control bead shows no effect on the localization of NoglacZ (D) and sma (F)-positive cells adjacent to the bead.
Yellow dashed lines indicate bead boundaries. BrdU immunostaining (orange) reveals uniform proliferation throughout the explants and does not detect
localized proliferation in response to an Fgf9 (G)- or Fgf10-loaded (H) bead. Counterstaining is DAPI (blue). All explants were treated with 3 g/ml Shh
for 72 h. BrdU labeling was performed for 4 h prior to fixation. Scale bar in (A), 300 m in (A, B); in (C), 200 m in (C–H).
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the first time, manipulate molecular factors in order to
assess their direct effects on the mesenchyme. We find that
recombinant N-Shh promotes both the proliferation of lung
mesenchyme and the differentiation of smooth muscle. By
contrast, signals from the mesothelium, particularly Fgf9,
inhibit at least some of the effects of N-Shh on mesenchyme
differentiation. We conclude that the endoderm and the
mesothelium normally work together to regulate the size
and fate of a pool of mesenchyme progenitor cells in the
distal lung. In the future, modifications of the culture sys-
tem, including the replacement of serum factors and the
identification of cell-autonomous markers for multiple spe-
cific mesodermal cell types, will allow these regulatory
mechanisms to be further explored.
Effect of Shh on lung mesenchyme differentiation
In vivo or in vitro, the expression of NoglacZ and sma is
tightly restricted to mesenchyme that is in close proximity
with lung endoderm, a tissue producing N-Shh (Figs. 1, 2,
and 5). By contrast, exogenous N-Shh in the culture me-
dium induces the expression of these markers throughout
the mesenchyme, with the exception of a peripheral zone
(discussed below). In this assay, the number of cells ex-
pressing markers for specific cell types (including NoglacZ
and sma) increases in a dose-dependent manner in response
to recombinant protein, illustrating that more mesodermal
cells have the potential to express these genes than normally
do so in vivo. This suggests that Shh not only supports the
survival and proliferation of preexisting cell types but also
(directly or indirectly) promotes the differentiation of pro-
genitor cells into specific lineages. Our bead studies further
show that Ptc and Bmp4lacZ are induced uniformly in the
mesenchyme in response to a localized source of Shh (Fig.
10). However, since markers of smooth muscle, such as
NoglacZ and sma, are not induced in a reproducible spatial
pattern around the bead, differentiation must be influenced
by other factors, such as local cell density and extracellular
matrix accumulation (Yang et al., 1999; Zhang et al., 1999).
Alternatively, or in addition, Shh may indirectly induce
these markers by affecting the expression of other signaling
molecules. Among the other factors that have been impli-
cated in promoting smooth muscle differentiation in the
lung are members of the platelet-derived growth factor
(Pdgf) and transforming growth factor  (Tgf) families of
signaling molecules (Bostrom et al., 1996; Bragg et al.,
2001; Lindahl et al., 1999; Sun et al., 2000; Zhou et al.,
1996).
(orange) reveals that smooth muscle cells are present, but are also not
restricted to the region immediately around the bead (I, J). Cells are
counterstained with DAPI. Neither Bmp4lacZ (K)- nor NoglacZ (L)-positive
cells are detected in explants cultured with PBS-loaded control beads (red
circles). Scale bars in (D), 200 m for (A, B); 100 m for (C, D, G, J); in
(F), 300 m for (E, F, K, L).
Fig. 10. Shh loaded beads induce localized Ptc and Bmp4lacZ. (A) Ptc
expression is detected in a localized domain around the Shh-loaded bead
(red circle) in explant culture (B). Phosphohistone H3 antibody staining
detects proliferating cells throughout the explant, not centered around the
bead (yellow circle) (C). DAPI counterstaining of the explant (D).
Bmp4lacZ is induced locally around a Shh-loaded bead (red circles), as
viewed both in whole-mount (E) and section (G). NoglacZ-positive cells are
also observed, but are not exclusively localized around the bead in either
whole mount (F) or section (H). Costaining of these sections for Sma
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Our results in culture provide evidence that Shh signal-
ing over an extended period promotes the differentiation of
lung mesenchyme into smooth muscle. This conclusion is
compatible with genetic studies implicating Shh, and its
downstream target Foxf1, in the differentiation of smooth
muscle in the normal lung (Kalinichenko et al., 2001b; Lim
et al., 2002; Mahlapuu et al., 2001; Pepicelli et al., 1998).
However, our results raise an apparent paradox: Shh is
normally expressed throughout the lung endoderm, with
highest levels in the distal tips, and Ptc transcription is also
highest in the distal mesenchyme, compared with mesen-
chyme around the proximal endoderm (Fig. 4). Yet, smooth
muscle cells are absent from these domains of distal meso-
derm. This paradox may be explained by the rapid out-
growth of respiratory endoderm during lung development in
vivo. After initial exposure to high levels of Shh at the
endoderm tip, the mesenchymal cells may move proximally
relative to the distal endoderm. This may be a passive
translocation, driven by endoderm outgrowth, and/or in-
volve active mesenchymal cell migration. By the time they
are competent to differentiate into smooth muscle, the mes-
enchyme cells are thus localized around proximal endoderm
(Fig. 11). These models will be tested in the future by using
lineage labeling techniques.
Endodermal and mesenchymal Bmp4 expression domains
are differentially regulated
Our studies reveal differential regulation of Bmp4 in the
endodermal and mesenchymal tissue layers of the lung. The
explant experiments provide evidence that Shh, normally
made by the endoderm, induces Bmp4 in lung mesenchyme,
at least at early stages of development. This finding is in
agreement with reports that Bmp4 transcripts are lost in Shh
mutant lung mesenchyme (Litingtung et al., 1998). More-
over, local induction of Bmp2/4 by Shh has been reported in
several other organs, including the hindgut (Roberts et al.,
1995; Sukegawa et al., 2000), the pituitary (Treier et al.,
2001), and the kidney (Yu et al., 2002). This contrasts with
endodermal regulation of Bmp4 in the lung, which is con-
trolled by localized Fgf signals, including Fgf10, in distal
mesenchyme (Hyatt et al., 2002; Lebeche et al., 1999;
Fig. 11. “Sandwich” model for patterning of lung mesenchyme. Mesenchymal cells (circles) are sandwiched between the mesothelium (pink) and the
endoderm (yellow). Signals from the mesothelium, such as Fgf9 (pink triangle), help to maintain peripheral cells in an undifferentiated or multipotent state.
Shh made by the endoderm (yellow triangle) promotes cell survival/proliferation, and also induces differentiation. Factors made by the more proximal
endoderm, including basal lamina proteins (black dotted line), promote terminal differentiation of parabronchial smooth muscle. Arrows indicate relative
movement of mesenchyme (gray) and endoderm (yellow). Open circles, multipotent cells; green circles, Nog-expressing cells; blue circles, Bmp4-expressing
cells; red circles, sma-positive cells. Cells can be positive for Nog, Bmp4, and sma, or any combination of these markers.
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Weaver et al., 2000). Taken together, these results empha-
size that the same gene, Bmp4, can be regulated by different
signals in adjacent cell populations. It is also likely that
there are stage-specific changes in the response of lung
mesenchyme to Shh, since our previous studies of trans-
genic embryos overexpressing Shh in lung endoderm
showed no change in the expression of Bmp4 in the lung at
E18.5 (Bellusci et al., 1997).
Factors made by the mesothelium regulate mesenchyme
differentiation
The mesothelium expresses high levels of Fgf9 from the
early pseudoglandular stage, and Fgf9/ lungs are smaller
than wild type (Colvin et al., 2001). Despite extensive
analysis, no missing cell types or other differentiation de-
fects are detected in these lungs. It has therefore been
suggested that Fgf9 from the mesothelium functions to
maintain the proliferation of distal mesenchyme, including
cells that express Fgf10 (Colvin et al., 2001). Our data
support this hypothesis and provide further novel evidence
that Fgf9 counteracts factors, including Shh, that promote
the differentiation of the mesenchyme. We hypothesize that
mesenchymal progenitor cells in the periphery of the devel-
oping lung, exposed to high levels of Fgf9 and relatively
low levels of Shh, are maintained in an undifferentiated
state (Fig. 11). However, we cannot rule out the possibility
that Fgf9 promotes their differentiation into peripheral mes-
enchymal cell types for which we do not yet have markers.
The differentiation state of the mesenchyme may be further
modulated by other factors made by the mesothelium, such
as Tgf3 (Bragg et al., 2001; Pelton et al., 1991) and
retinoic acid (Malpel et al., 2000; Niederreither et al., 2002).
Conclusion: “sandwich” model for the patterning of
mesenchyme during early lung development
In summary, we propose the following model for lung
mesenchyme development, as depicted in Fig. 11:
In the early lung, mesenchyme is “sandwiched” between
two distinct tissues: the endoderm and the mesothelium.
From the interior of the lung, Shh produced by the
endoderm promotes the proliferation of the mesenchyme,
possibly by acting as a direct mitogen and modulating the
levels of intracellular cyclins (Barnes et al., 2001; Duman-
Scheel et al., 2002; Long et al., 2001). In addition, Shh may
have roles in controlling cell fate and cell differentiation.
However, whether it acts directly as a morphogen, as in the
vertebrate neural tube (for review, see Marti and Bovolenta,
2002), or indirectly by inducing mesenchymal factors such
as Bmp4, remains an open question. Toward the periphery,
the cells come under the influence of the mesothelium,
which inhibits stromal cell differentiation and thereby helps
to maintain a local population of multipotent progenitor
cells. Fgf9 plays an important role in this process. Future
studies will be directed at identifying molecular markers for
mesenchymal progenitor populations and at clarifying how
signals from both the endoderm and mesothelium regulate
differentiation and patterning.
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